Relating to the use, possession, delivery, or manufacture of testing equipment that identifies the presence of a substance listed in Penalty Group 1-B.

SB 362 exempts legitimate use of testing equipment that identifies serious drugs (like heroin or cocaine, listed in Penalty Group 1-B) from certain drug possession and distribution laws. It specifically clarifies that forensic labs, medical facilities, or other authorized entities using such equipment for testing purposes are not subject to penalties under Health and Safety Code Section 481.125. The bill applies only to offenses occurring on or after its effective date (September 1, 2025), leaving prior law in effect for past actions. This change directly affects laboratories and healthcare providers conducting drug testing, ensuring they can operate without unintended legal consequences.